OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic potential of cannabinoid medicines
Philip Robson
Drug Testing and Analysis (2013) Vol. 6, Iss. 1-2, pp. 24-30
Closed Access | Times Cited: 117
Philip Robson
Drug Testing and Analysis (2013) Vol. 6, Iss. 1-2, pp. 24-30
Closed Access | Times Cited: 117
Showing 1-25 of 117 citing articles:
E-Cigarettes: A Review of New Trends in Cannabis Use
Christian Giroud, Mariangela De Cesare, Aurélie Berthet, et al.
International Journal of Environmental Research and Public Health (2015) Vol. 12, Iss. 8, pp. 9988-10008
Open Access | Times Cited: 227
Christian Giroud, Mariangela De Cesare, Aurélie Berthet, et al.
International Journal of Environmental Research and Public Health (2015) Vol. 12, Iss. 8, pp. 9988-10008
Open Access | Times Cited: 227
Therapeutic advances in obesity management: an overview of the therapeutic interventions
Moody Al Roomy, Kainat Hussain, Hawraa M. Behbehani, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 18
Moody Al Roomy, Kainat Hussain, Hawraa M. Behbehani, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 18
Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence
Bertrand Redonnet, Filiz Eren, Guillaume Avenin, et al.
Addiction (2025)
Open Access | Times Cited: 2
Bertrand Redonnet, Filiz Eren, Guillaume Avenin, et al.
Addiction (2025)
Open Access | Times Cited: 2
Cannabis, cannabidiol, and epilepsy — From receptors to clinical response
Jerzy P. Szaflarski, E. Martina Bebin
Epilepsy & Behavior (2014) Vol. 41, pp. 277-282
Closed Access | Times Cited: 150
Jerzy P. Szaflarski, E. Martina Bebin
Epilepsy & Behavior (2014) Vol. 41, pp. 277-282
Closed Access | Times Cited: 150
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK
David J. Potter
Drug Testing and Analysis (2013) Vol. 6, Iss. 1-2, pp. 31-38
Closed Access | Times Cited: 148
David J. Potter
Drug Testing and Analysis (2013) Vol. 6, Iss. 1-2, pp. 31-38
Closed Access | Times Cited: 148
Considering Marijuana Legalization: Insights for Vermont and Other Jurisdictions
Jonathan P. Caulkins, Beau Kilmer, Mark A. R.Kleiman, et al.
RAND Corporation eBooks (2015)
Open Access | Times Cited: 130
Jonathan P. Caulkins, Beau Kilmer, Mark A. R.Kleiman, et al.
RAND Corporation eBooks (2015)
Open Access | Times Cited: 130
The role of cannabinoids in adult neurogenesis
Jack Prenderville, Aine Marie Kelly, Eric J. Downer
British Journal of Pharmacology (2015) Vol. 172, Iss. 16, pp. 3950-3963
Open Access | Times Cited: 117
Jack Prenderville, Aine Marie Kelly, Eric J. Downer
British Journal of Pharmacology (2015) Vol. 172, Iss. 16, pp. 3950-3963
Open Access | Times Cited: 117
Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications
Yufeng Wei, Rameen Shah
Pharmaceuticals (2020) Vol. 13, Iss. 7, pp. 155-155
Open Access | Times Cited: 113
Yufeng Wei, Rameen Shah
Pharmaceuticals (2020) Vol. 13, Iss. 7, pp. 155-155
Open Access | Times Cited: 113
Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study
Louisa Degenhardt, Nicholas Lintzeris, Gabrielle Campbell, et al.
Drug and Alcohol Dependence (2014) Vol. 147, pp. 144-150
Closed Access | Times Cited: 106
Louisa Degenhardt, Nicholas Lintzeris, Gabrielle Campbell, et al.
Drug and Alcohol Dependence (2014) Vol. 147, pp. 144-150
Closed Access | Times Cited: 106
Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor
María Rodríguez-Muñoz, Yara Onetti, Elsa Cortés‐Montero, et al.
Molecular Brain (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 104
María Rodríguez-Muñoz, Yara Onetti, Elsa Cortés‐Montero, et al.
Molecular Brain (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 104
Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.
Lisa R. Bartner, Stephanie McGrath, Sangeeta Rao, et al.
PubMed (2018) Vol. 82, Iss. 3, pp. 178-183
Closed Access | Times Cited: 102
Lisa R. Bartner, Stephanie McGrath, Sangeeta Rao, et al.
PubMed (2018) Vol. 82, Iss. 3, pp. 178-183
Closed Access | Times Cited: 102
Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis
Sonali S. Bharate, Serge Mignani, Ram A. Vishwakarma
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 23, pp. 10345-10374
Closed Access | Times Cited: 87
Sonali S. Bharate, Serge Mignani, Ram A. Vishwakarma
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 23, pp. 10345-10374
Closed Access | Times Cited: 87
Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain
Hayes Wong, Brian E. Cairns
Archives of Oral Biology (2019) Vol. 104, pp. 33-39
Closed Access | Times Cited: 79
Hayes Wong, Brian E. Cairns
Archives of Oral Biology (2019) Vol. 104, pp. 33-39
Closed Access | Times Cited: 79
Weight management in obesity – past and present
David Haslam
International Journal of Clinical Practice (2016) Vol. 70, Iss. 3, pp. 206-217
Open Access | Times Cited: 85
David Haslam
International Journal of Clinical Practice (2016) Vol. 70, Iss. 3, pp. 206-217
Open Access | Times Cited: 85
Emerging drugs for neuropathic pain
Ian Gilron, Anthony H. Dickenson
Expert Opinion on Emerging Drugs (2014) Vol. 19, Iss. 3, pp. 329-341
Closed Access | Times Cited: 73
Ian Gilron, Anthony H. Dickenson
Expert Opinion on Emerging Drugs (2014) Vol. 19, Iss. 3, pp. 329-341
Closed Access | Times Cited: 73
Cannabinoid modulation of drug reward and the implications of marijuana legalization
Dan P. Covey, Jennifer M. Wenzel, Joseph F. Cheer
Brain Research (2014) Vol. 1628, pp. 233-243
Open Access | Times Cited: 72
Dan P. Covey, Jennifer M. Wenzel, Joseph F. Cheer
Brain Research (2014) Vol. 1628, pp. 233-243
Open Access | Times Cited: 72
The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation
Zaid H. Maayah, Shingo Takahara, Mourad Ferdaoussi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 7, pp. 165771-165771
Closed Access | Times Cited: 69
Zaid H. Maayah, Shingo Takahara, Mourad Ferdaoussi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 7, pp. 165771-165771
Closed Access | Times Cited: 69
Phytocannabinoids and epilepsy
Rafael G. dos Santos, Jaime E. C. Hallak, João Pereira Leite, et al.
Journal of Clinical Pharmacy and Therapeutics (2014) Vol. 40, Iss. 2, pp. 135-143
Open Access | Times Cited: 68
Rafael G. dos Santos, Jaime E. C. Hallak, João Pereira Leite, et al.
Journal of Clinical Pharmacy and Therapeutics (2014) Vol. 40, Iss. 2, pp. 135-143
Open Access | Times Cited: 68
Neural correlates of interactions between cannabidiol and Δ9‐tetrahydrocannabinol in mice: implications for medical cannabis
Stephanie M. Todd, Jonathon C. Arnold
British Journal of Pharmacology (2015) Vol. 173, Iss. 1, pp. 53-65
Open Access | Times Cited: 67
Stephanie M. Todd, Jonathon C. Arnold
British Journal of Pharmacology (2015) Vol. 173, Iss. 1, pp. 53-65
Open Access | Times Cited: 67
Synthesis and Characterization of the Diastereomers of HHC and H4CBD
Arianna C. Collins, Giovanni A. Ramirez, Tesfay Tesfatsion, et al.
Natural Product Communications (2023) Vol. 18, Iss. 3
Open Access | Times Cited: 20
Arianna C. Collins, Giovanni A. Ramirez, Tesfay Tesfatsion, et al.
Natural Product Communications (2023) Vol. 18, Iss. 3
Open Access | Times Cited: 20
Pure Cannabidiol in the Treatment of Malignant Migrating Partial Seizures in Infancy: A Case Report
Dimah Saade, Charuta Joshi
Pediatric Neurology (2015) Vol. 52, Iss. 5, pp. 544-547
Closed Access | Times Cited: 64
Dimah Saade, Charuta Joshi
Pediatric Neurology (2015) Vol. 52, Iss. 5, pp. 544-547
Closed Access | Times Cited: 64
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
Celina S. Liu, Sarah Chau, Myuri Ruthirakuhan, et al.
CNS Drugs (2015) Vol. 29, Iss. 8, pp. 615-623
Closed Access | Times Cited: 56
Celina S. Liu, Sarah Chau, Myuri Ruthirakuhan, et al.
CNS Drugs (2015) Vol. 29, Iss. 8, pp. 615-623
Closed Access | Times Cited: 56
Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain
Edgar Rangel‐López, Ana Laura Colín-González, A.L. Paz-Loyola, et al.
Neuroscience (2014) Vol. 285, pp. 97-106
Closed Access | Times Cited: 53
Edgar Rangel‐López, Ana Laura Colín-González, A.L. Paz-Loyola, et al.
Neuroscience (2014) Vol. 285, pp. 97-106
Closed Access | Times Cited: 53
Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV− adults
April D. Thames, Taylor Kuhn, Timothy J. Williamson, et al.
Drug and Alcohol Dependence (2016) Vol. 170, pp. 120-127
Open Access | Times Cited: 52
April D. Thames, Taylor Kuhn, Timothy J. Williamson, et al.
Drug and Alcohol Dependence (2016) Vol. 170, pp. 120-127
Open Access | Times Cited: 52
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
Yara Mouhamed, Andrey E. Vishnyakov, Bessi Qorri, et al.
Drug Healthcare and Patient Safety (2018) Vol. Volume 10, pp. 45-66
Open Access | Times Cited: 52
Yara Mouhamed, Andrey E. Vishnyakov, Bessi Qorri, et al.
Drug Healthcare and Patient Safety (2018) Vol. Volume 10, pp. 45-66
Open Access | Times Cited: 52
